Global X Genomics & Biotechnology UCITS ETF

PhysicalIndex replication
AccumulatingDistribution policy
0.50 %TER
£100.01M Fund size
51Number of positions
— TD
42.83 %Top 10 share
USDCurrency
6SRI

Current price

£7.96
19 Nov 2026
1D
1W
1M
3M
6M
1Y
3Y
Max

Description

The Fund’s investment objective is to generate returns that closely correspond, before fees and expenses, generally to the price and yield performance of the Solactive Genomics v2 Index (the “Index”). The Fund is passively managed. The Fund will aim to achieve its investment objective by attempting to replicate the performance of the Index by investing primarily in a portfolio of equity securities that as far as possible and practicable consists of the component securities of the Index in similar proportions to their weightings in the Index and in american depositary receipts (“ADRs”) and global depositary receipts (“GDRs”) based on the securities in the Index. The Index aims to provide exposure to exchange-listed companies that are positioned to benefit from advances in genomic science and biotechnology. A company must derive at least 50% of its revenue, operating income, or assets from genomics and/or biotechnology to be considered for inclusion in the Index. Genomic and Biotechnology Companies include those involved in the following business activities (i) genomic editing, (ii) genomic sequencing, (iii) development and testing of genetic medicine/therapies, (iv) computational genomics and genetic diagnostics, and/or, (v) biotechnology. When not possible or practicable to continue to hold all of the component securities of the Index, the Fund may invest in depositary receipts relating either to components securities of the Index or to equity securities of the type referred to above; and financial derivative instruments (“FDIs”), namely, total return “unfunded” OTC swaps and exchange-traded equity futures for investment purposes. The Fund may enter into securities lending transactions, investing in repurchase and reverse repurchase transactions and short term money market collective investment schemes, for the purposes of efficient portfolio management only. The Fund’s base currency is USD. For Accumulating Shares, income will be automatically reinvested in the Fund and reflected in the NAV per share. Investors can buy and sell shares of the Fund on each business day. Business day means a day on which the New York Stock Exchange and London Stock Exchange are open for normal business. For more information about the investment policy and strategy of the Fund, please refer to the sections entitled “Investment Objective” and “Investment Policy” in the Fund’s Supplement.

Return

Here you can see the performance (incl. distributions) of the Global X Genomics & Biotechnology UCITS ETF.

Period Perfor­mance
1 Week-7.73 %
1 Month-6.39 %
3 Months+4.38 %
6 Months+37.14 %
1 Year+39.79 %
3 Years+37.93 %(11.31 % p.a.)
5 Years-27.31 %(-6.18 % p.a.)
10 Years—
Since inception -28.88 %(-6.54 % p.a.)
Year Perfor­mance
YTD+33.28 %
2025+4.81 %
2024-10.44 %
2023-11.72 %
2022-31.96 %
2021-4.84 %
As of: 18 Nov 2026. Performance displayed in GBP

Master data

Key master data for the Global X Genomics & Biotechnology UCITS ETF

Total expense ratio (TER) 0.50 %
Index replication Physical
Replication method Full
Distribution policy Accumulating
Fund size £100.01M
Fund launch 2 Nov 2021
Fund currency USD
Currency hedging No 
Fund domicileIrland
Risk indicator (SRI)
6 · second-highest risk class

Risk metrics

Key risk and analysis metrics for the Global X Genomics & Biotechnology UCITS ETF

Volatility
27.28 % 1 Year
29.52 % 3 Years
— 5 Years
max. Drawdown
-8.54 % 1 Year
-35.26 % 3 Years
— 5 Years
Sharpe Ratio
1.62 1 Year
0.77 3 Years
— 5 Years
XLM
48.71

Information about the Solactive Genomics v2 USD Index

Index name Solactive Genomics v2 USD (1)
Included securities 55
Stock positions 51
Bond positions 0
Cash and other positions 4

More ETFs tracking the Solactive Genomics v2 USD Index

Here you can find alternative index funds for the Solactive Genomics v2 USD.

Fund nameWKNTER
No results

Frequently asked questions

Here you will find all answers to your questions about the Global X Genomics & Biotechnology UCITS ETF

Master data is provided by Morningstar (stocks, ETFs, funds), CoinGecko (cryptocurrencies) and Isarvest GmbH. Price data is at least 15-minute delayed exchange prices (stocks, ETFs, funds) or NAV prices (ETFs, funds). Real-time prices – where available – are provided by the providers and Lang & Schwarz (stocks, ETFs, funds) and CoinGecko (cryptocurrencies).

Isarvest GmbH assumes no liability for the information presented and cannot guarantee that the data is complete and accurate.

Affiliate notice *
Links marked with an asterisk (*) are advertising or affiliate links. If you purchase or sign up through this link, we receive compensation from the provider. This comes at no additional cost or disadvantage to you. We use this revenue to fund our free services. Thank you for your support.